Adcock Ingram painkiller infringes Aspen trademark, high court rules
Pharmaceutical giant’s smaller rival barred from selling and distributing Lenbucod
18 May 2025 - 16:17
Adcock Ingram has been barred by a court order from selling and distributing its newly launched painkilling drug, Lenbucod, which the Pretoria high court found infringed Aspen’s Mybucod.
The sparring between the two JSE-listed pharmaceuticals is the latest trademark battle in the industry — with companies increasingly taking legal action to protect their turf...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.